HLA-DRB1 association with schizophrenia in Saudi Arabian patients

References

• Saha S, Chant D, Welham J, McGrath J. A systemic review of the prevalence of schizophrenia. PLoS Med 2005;2(5): e141.
   PubMedGoogle Scholar
• McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence of mortality. Epidemiol Rev 2008;30:67–76.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th. Washington, DC: American Psychiatric Press; 1994.
   Google Scholar
• Salem JE, Kring AM. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clin Psychol Rev 1998;18(7):795–819.
   PubMedGoogle Scholar
• Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000;401:3–38.
   PubMedGoogle Scholar
• Owen M, McGuffin P. The molecular genetics of schizophrenia. Br Med J 1992;305:664–5.
   PubMedGoogle Scholar
• Lieberman JA, Stroup TS, Perkins DO. The American Psychiatric Publishing Textbook of Schizophrenia. 1st. Washington, DC: American Psychiatric Publishing; 2006.
   Google Scholar
• Bassett AS, Chow EWC, Waterworth DM, Brzustowicz L. Genetic insights into schizophrenia. Can J Psychiatry 2001; 46:131–7.
   PubMedGoogle Scholar
• Wei J, Hemmings GP. Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia. Med Hypothesis 2005;64:547–52.
   PubMedGoogle Scholar
• Barondes SH, Alberts BM, Andreassen NC, Bargmenn C, Benes F, Goldman-Rokic P, . Workshop on schizophrenia. Proc Natl Acad Sci USA 1997;19:1612–14.
   Google Scholar
• Gibson S, Hawi Z, Straub RE, Walsh D, Kendler KS, Gill M. HLA and schizophrenia: refutation of reported associations with A9 (A23/A24), DR4, and DQB1*0602. Am J Med Genet 1999;88(4):416–21.
   PubMedGoogle Scholar
• Schwab SG, Hallmeyer J, Freimann J, Lerer B, Albus, M, Bormann-Hassenbach M, . Investigations of linkage and association /linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-, alleles in 69 sib- pairs- and 89 Trio- families with schizophrenia. Am J Med Genet 2002;114: 315–20.
   PubMed Web of Science ®Google Scholar
• Schwab SG, Albus M, Hallmeyer J, Honig S, Borrmann M, Lichtermann D, . Evaluation of susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 1995;11:325–27.
   PubMed Web of Science ®Google Scholar
• Nunes SOV, Borelli SD, Matsuo T, Watanabe MAE, Itano EN. The association of the HLA in patients with schizophrenia, schizoaffective disorder, and in their biological relatives. Schizophr Res 2005;76:195–8.
   PubMedGoogle Scholar
• Ozcan, ME. Human leukocyte antigen DR1 in Japanese and Turkish patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:423–8.
   PubMedGoogle Scholar
• Narita K, Sasaki T, Akaho R, Okazaki Y, Kusumi I, Kato T, . Human leukocyte antigen and season of birth in Japanese patients with schizophrenia. Am J Psychiatry 2000;157(7):1173–5.
   PubMedGoogle Scholar
• Ozcan ME, Taskin R, Banoglu R, Babacan M, Tuncer E. HLA antigens in schizophrenia and mood disorders. Biol Psychiatry 1996;39:891–5.
   PubMed Web of Science ®Google Scholar
• Haider MZ, Zahiz MA, Dalal HN, Razik MA. Human leukocyte antigen (HLA) DRB1 alleles in Kuwaiti Arabs with schizophrenia. Am J Med Genet 2000;96:870–2.
   PubMed Web of Science ®Google Scholar
• Johnstone EC, Ebmeier KP, Miller P, Owens DGC, Lawrie SM. Predicting schizophrenia: findings from the Edinburgh High-risk study. Br J Psychiatry 2005;186:18–25.
   PubMed Web of Science ®Google Scholar
• Al-Swailem R, Al-Rayes H, Sobkil S, Arfin M, Tariq M. HLA-DRB1 association in Saudi rheumatoid arthritis patients. Rheumatol Int 2006;26: 1019–24.
   PubMedGoogle Scholar
• Schallreuter KU, Levenig C, Kuhnl P, Loliger C, Hohl-Tehari M, Berger J. Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from Northern Germany. Dermatology 1993;187:186–92.
   PubMed Web of Science ®Google Scholar
• Savejgaard A, Platz P, Ryder LP. HLA and disease 1982–A survey. Immunol Rev 1983;70:193–218.
   PubMedGoogle Scholar
• Al-Abdulkareem AA, Ballal SG. Consanguineous marriage in an urban area of Saudi Arabia: rates and adverse health effects on the offspring. J Commun Health 1998;23:75–83.
   PubMed Web of Science ®Google Scholar
• Seliem MA, Bou-Holaigah IH, Al-Sannaa N. Influence of consanguinity on the pattern of familial aggregation of congenital cardiovascular anomalies in an outpatient population: studies from the eastern province of Saudi Arabia. Commun Genet 2007;10:27–31.
   PubMedGoogle Scholar
• Al-Jarallah AS. Down's syndrome and the pattern of congenital heart disease in a community with high parental consanguinity. Med Sci Monit 2009;15(8):CR409–12.
   PubMedGoogle Scholar
• Dobrusin M, Weitzman D, Levine J, Kremer I, Rietschel M, Maier WH, Belmaker RH. The rate of consanguineous marriages among parents of schizophrenic patients in the Arab Bedouin population in Southern Israel. World J Biol Psychiatry 2008;11:1–3.
   Google Scholar
• Wright P, Donaldson P, Underhill J, Chouhuri K, Doheety D, Murray RM. Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am J Psychiatry 1996;153:1530–3.
   PubMed Web of Science ®Google Scholar
• Tokunaga K, Imanishi T, Takahashi K, Juji T. On the origin and dispersal of East Asian populations as reviewed from HLA haplotypes. Akazawa T, Szathmary EJ. Prehistoric mongoloid dispersals. Oxford: Oxford University Press; 1996. 187–97.
   Google Scholar
• Hawi Z, Gibson S, Straub RE, Walsh D, Kendler KS, Gill M. Schizophrenia and HLA: No association with PCRSSOP typed classical loci in a large Irish familial sample. Am J Med Genet 1999;88(4):422–9.
   PubMedGoogle Scholar
• Douglass AB, Shipley JE, Haines RF, Scholten RC, Dudley E, Tapp A. Schizophrenia, narcolepsy, and HLA-DR15, DQ6. Biol Psychiatry 1993;34:773–80.
   PubMedGoogle Scholar
• Sette A, Buus S, Colon S, Smith JA, Miles C, Grey HM. Structural characteristics of an antigen required for its interaction with HLA and recognized by T cells. Nature 1987; 328:395–9.
   PubMed Web of Science ®Google Scholar
• Roitt IM. Essential immunology. Oxford: Blackwell Scientific; 1991.
   Google Scholar
• Ganguli R, Yang Z, Shurin G, Chengappa KN, Brar, JS, Gubbi AV, . Serum interleukin-6 concentrations in schizophrenia: elevation association with duration of illness. Psychiatry Res 1994;51:1–10.
   PubMed Web of Science ®Google Scholar
• Rapaport MH, Lohr JB. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand 1994;90(5):311–5.
   PubMedGoogle Scholar
• Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and lnterleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 1995;29:141–52.
   PubMed Web of Science ®Google Scholar
• Gaughran F, O'Neill E, Cole M, Collins K, Daly RJ, Shanhan F. Increased soluble interleukin-2 receptor levels in schizophrenia. Schizophr Res 1998;29:263–7.
   PubMed Web of Science ®Google Scholar
• Lin A, kenis G, Bignotti S, Tura GJ, De Jong R, Bosmans E, . The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res 1998;32:9–15.
   PubMed Web of Science ®Google Scholar
• Yu L, Yang MS, Zhao J, Shi YY, Zhao XZ, Yang JD, . An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophr Res 2004;71(1):179–83.
   PubMedGoogle Scholar
• Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatr 2004;65(7):940–7.
   PubMedGoogle Scholar
• Jacobs K. Schizophrenia and the immune system. Harv Sci Rev 2006;46–8.
   Google Scholar
• Yu YQ, Yu Q, Guo YJ, Sang H, Shi JP, Liu SZ, Wei J. Study on the genetic association between DRB3 and DRB1 loci in the human MHC region and psychotic symptoms of schizophrenia. Zhonghua Liu Xing Bing Xue Za Zhi 2003;24:815–8.
   PubMedGoogle Scholar
• Li T, Underhill J, Liu X, Sham P, Donaldson P, Murray R, Wright P, Collier DA. Transmission disequilibrium analysis of HLA class II DRB1, DQA1, DQB1 and DPB1 polymorphisms in schizophrenia using family trios from a Han Chinese population. Schizophr Res 2001;49:73–8.
   PubMedGoogle Scholar
• Sasaki T, Matsushita M, Nanko S, Fukuda R, Kennedy JL, Tokunaga K. Schizophrenia and the HLA-DRB1 gene in the Japanese population. Am J Psychiatry 1999;156(5):771–3.
   PubMedGoogle Scholar
• Miyanaga K, Machiyama Y, Juji T. Schizophrenia disorders and HLA-DR antigens. Biol Psychiatry 1984;19:121–9.
   PubMedGoogle Scholar
• Arinami T, Otsuka Y, Hamaguchi H, Itokawa M, Aoki J, Shibuya H. Evidence supporting an association between DRB1 gene and schizophrenia in Japanese. Schizophr Res 1998;32:81–6.
   PubMedGoogle Scholar
• Akaho R, Matsubita I, Narita K, Okazaki Y, Okabe Y, Matsushita M. Support for an association between HLA-DR1 and schizophrenia in the Japanese population. Am J Med l Genet 2000;96:725–7.
   PubMedGoogle Scholar